Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 58, 2003 - Issue 1
13
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

ANTIBIOTIC SUSCEPTIBILITY AND SEROTYPE DISTRIBUTION OF 240 STREPTOCOCCUS PNEUMONIAE CAUSING MENINGITIS IN BELGIUM 1997-2000

, , , , &
Pages 19-26 | Published online: 30 May 2014
 

Abstract

Cerebrospinal fluid isolates of Streptococcus pneumoniae, collected during the years 1997-2000 at more than 100 Belgian laboratories were studied. The 10 most common serotypes-serogroups representing 76 % of the isolates were 14, 6, 9, 19, 23, 18, 4, 10, 8 and 12 (in order of frequency). Thirty-six percent of strains were isolated in children < 5 years old. In this age group the number of serogroups was more limited and 81.4 % are included in the 7-valent conjugate vaccine. Decreased susceptibility to penicillin was observed in 13.9 % of 237 strains (MIC > 0.06 mg/L), with only 2.1 % resistant strains (MIC > 1 mg/L). Twelve strains showed reduced susceptibility to cefotaxime (MIC > 0.5 mg/L). Only three of the 237 strains were intermediately susceptible to meropenem. All strains were susceptible to vancomycin and moxifloxacin.

In Belgium, high doses of third generation cephalosporins remain effective for the treatment of pneumococcal meningitis. The new fluoroquinolones seem the most promising agents for the treatment of pneumococcal meningitis in the future.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.